Evidence map›Paper›PMID 40329190›Full record

SynthesisBMC cancer2025

Use of cultural appropriateness strategies and behavioral frameworks in behavioral interventions for black and hispanic cancer survivors: a systematic review.

Evelyn Arana-Chicas, Yingting Zhang, Arlette Chávez-Iñiguez, Po-Ju Lin, Lindsey J Mattick, Charles Kamen, Viktor Clark, Francisco Cartujano-Barrera, Karen M Mustian

Abstract readSystematic Review
In one paragraph

Synthesis in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2026
    Article
  5. Article
  6. A four-phase framework for culturally responsive vaccine messaging.Health psychology and behavioral medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Evelyn Arana-ChicasDepartment of Medicine, Rutgers Cancer Institute, 120 Albany Street, 8th Floor, Tower 2, New Brunswick, NJ, 08901, USA. earana@cinj.rutgers.edu.ORCID http://orcid.org/0000-0001-8666-6468
Yingting ZhangRobert Wood Johnson Library of the Health Sciences, Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, 1 RWJ Place, New Brunswick, NJ, 08901, USA.
Arlette Chávez-IñiguezDepartment of Medicine, Rutgers Cancer Institute, 120 Albany Street, 8th Floor, Tower 2, New Brunswick, NJ, 08901, USA.
Po-Ju LinJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, 265 Crittenden Blvd, Rochester, NY, 14642, USA.
Lindsey J MattickJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, 265 Crittenden Blvd, Rochester, NY, 14642, USA.
Charles KamenJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, 265 Crittenden Blvd, Rochester, NY, 14642, USA.
Viktor ClarkJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, 265 Crittenden Blvd, Rochester, NY, 14642, USA.
Francisco Cartujano-BarreraDepartment of Public Health Sciences, University of Rochester School of Medicine and Dentistry, 265 Crittenden Blvd, Rochester, NY, 14642, USA.
Karen M MustianJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, 265 Crittenden Blvd, Rochester, NY, 14642, USA.

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7M
NCI NIH HHS T32 CA102618NCI NIH HHS UG1 CA189961
6 · The paper itself

Abstract

backgroundBlack and Hispanic cancer survivors experience significant inequities in supportive cancer care. Incorporating cultural appropriateness strategies and behavioral frameworks into supportive care interventions can improve cancer outcomes of Black and Hispanic survivors. This review evaluated behavioral oncology trials for Black and Hispanic cancer survivors to assess their use of cultural appropriateness strategies and behavioral frameworks.

methodsA systematic search was conducted across seven databases with a cutoff date of November 15, 2023: 1) PubMed, 2) Cochrane Central Register of Controlled Trials, 3) Embase, 4) Cumulative Index of Nursing and Allied Health Literature, 5) APA PsycInfo, 6) Scopus, and 7) Web of Science. Studies with Black or Hispanic cancer survivors, with or without a comparator, were included.

resultsThirty-seven trials met the inclusion criteria. Most focused on Black survivors (n = 19, 51.4%) and breast cancer survivors (n = 32, 86.5%). Most were psychosocial interventions addressing quality of life or distress (n = 20, 54.1%). Culturally appropriate strategies were reported in 86.5% (n = 32) of trials, with the most common being sociocultural (n = 30, 81.1%;), constituent-involving (n = 27, 73.0%;), and linguistic (n = 20, 54.1%;). Behavioral frameworks were reported in 56.8% (n = 21) of trials, with Social Cognitive Theory (n = 10, 52.6%) and Stress and Coping Theory (n = 3, 15.8%) being the most frequent. Less than half combined cultural adaptation strategies and a behavioral framework (n = 18, 48.6%).

conclusionWhile most trials incorporated cultural appropriateness strategies, fewer utilized behavioral frameworks, and even fewer used both. Future research should integrate these approaches to improve cancer outcomes and address disparities.

Indexed as

Behavior TherapyBlack or African AmericanCancer SurvivorsCultural CompetencyHispanic or LatinoNeoplasmsClinical Trials as TopicCulturally Competent CareFemaleHumansQuality of LifeBehavioral frameworkCancer survivorsCultural appropriatenessHealth disparitiesRacial and ethnic minorities

Identifiers

PMID40329190
PMCPMC12057219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.